Bentham Science Logo
Track your manuscript:


Browse Contents
Select Volume:  

Select Issue:  

Select Article:


Special Offers


Articles submitted between January 01st to March 31st, 2019 will be published as Open Access. Open Access publishing provides greater accessibility to the article. To view some of the Open access articles in the journal, please click here



Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.



30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published. Multiple issue copies at discounted rates.


Abstracted/Indexed in





Endorsements

"Current Pharmacogenomics and Personalized Medicine provides access to the most recent progress and opinion in this rapidly developing field and is an indispensable source of information for scientists and clinicians who want to keep in touch with the expanding interdisciplinary advancements."

Brian Tomlinson
Professor of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR.

Forthcoming Special Issues
Please visit again after some time to view these Issues.
Special Issues - In-Press
Please visit again after some time to view these Issues.
Published Special Issues

Validation of traditional medicinal practices through modern scientific tools and techniques


Current Pharmacogenomics and Personalized Medicine, Volume 16, Number 01
Guest Editor(s): Vijay Kothari

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)

,

Volume 16

-

Number 2



Biography   Open Access



Review Article



Review Article



Review Article   Open Access



Research Article



Research Article



Research Article   Open Access



Research Article   Open Access



Abstracts Ahead of Print

There are currently no Abstracts Ahead of Print available for this journal.

Editor's Choice


The Gut Microbiota in Cardiovascular Diseases: From Biomarkers and Potential Targets to Personalized Interventions

, 2018; 16(1): 75 - 85

Yaroslav I. Ashikhmin, Abram L. Syrkin, Andrey A. Zamyatnin Jr.*, Yong Zhang and Philipp Yu. Kopylov*


DOI: 10.2174/1875692116666180511170329




Cardiovascular Pharmacogenomics

, 2017; 15(1): 67 - 80

Valentina Manzo*, Sara Tarallo, Teresa Iannaccone, Maria Costantino, Walter Filippelli and Amelia Filippelli


DOI: 10.2174/1875692115666170503124456



Gender Differences in Response to Therapy for Cardiovascular Diseases

, 2017; 15(1): 14 - 26

Corbi Graziamaria*, Ambrosino Immacolata, Komici Klara, Cellurale Michele, Lombardi Anna and Ferrara Nicola


DOI: 10.2174/1875692115666170508153322



Allele Frequencies of CYP2D6, CYP3A5 and DPYD Genes Polymorphisms in the Healthy Yakut Population

, 2016; 14(1): 50 - 55

Filipp F. Vasilyev, Diana A. Danilova, Vladimir S. Kaimonov, Yana V. Chertovskih and Nadezda R. Maksimova


DOI: 10.2174/1875692114666160801151257




Exome-wide pharmacogenomic analysis of response to thiopurines in inflammatory bowel disease patients

, 2015; 13(1): 61 - 67

William Zabala, Raquel Cruz, Manuel Barreiro-de Acosta, María Chaparro, Julián Panes, Ana Echarri, Maria Esteve, Daniel Carpio, Montserrat Andreu, Esther Garcia-Planella, Eugeni Domenech, Angel Carracedo, Javier P. Gisbert, Francisco Barros and on behalf of EIGA and ENEIDA investigators


DOI: 10.2174/1875692113666150813151413





Open Access Articles

Individualized Cancer Therapy, Future Approaches

, 2018; 16(2): 156 - 163

Da-Yong Lu*, Ting-Ren Lu, Bin Xu, Jin-Yu Che, Ying Shen and Nagendra Sastry Yarla



















Most Cited Articles

Cardiovascular Pharmacogenomics

, 2017; 15(1): 67-80.

Valentina Manzo*, Sara Tarallo, Teresa Iannaccone, Maria Costantino, Walter Filippelli and Amelia Filippelli


DOI: 10.2174/1875692115666170503124456



Impact of New Technologies on Pharmacogenomics

, 2016; 14(2): 74-85.

Maria Isidoro-Garcia*, Almudena Sanchez-Martin and Belen Garcia-Berrocal


DOI: 10.2174/1875692115666170214152152



Most Accessed Articles



The Gut Microbiota in Cardiovascular Diseases: From Biomarkers and Potential Targets to Personalized Interventions

, 2018; 16(1): 75-85.

Yaroslav I. Ashikhmin, Abram L. Syrkin, Andrey A. Zamyatnin Jr.*, Yong Zhang and Philipp Yu. Kopylov*


DOI: 10.2174/1875692116666180511170329







Webmaster Contact: info@benthamscience.net
Copyright © 2018 Bentham Science | Privacy Policy